Nursery health measures

(1) When each batch of piglets is transferred, they are bred in nests or sorted by a weak and strong size to prevent the pigs from fighting.

(2) In order to prevent newly transmitted piglets from undergoing stress reactions and diseases of the intestine and respiratory tract, antibiotics can be prevented by feeding or drinking water at the time of transfer.

(3) Nursery pigs should be immunized for the second time around the age of 60 days. When foot-and-mouth disease is likely to occur in neighboring countries and regions, vaccines must be given twice a week after the immunization program. The second time can also be used for After transfer to the finishing house), and should selectively inject erysipelas, porcine plague, pseudorabies, porcine reproductive and respiratory syndrome, porcine contagious atrophic rhinitis, porcine infectious pleura in accordance with the local epidemic and possible outbreaks. Vaccines such as pneumonia, asthma, swine streptococcus, transmissible gastroenteritis, swine epidemic diarrhea, etc. If there are many kinds of vaccines that need to be injected, they can also be injected into the rearing house when the nursery is injecting. .

(4) Doll pigs have to castrate.

(5) Deworming for the first time around the age of 2 months.

(6) Pay attention to the prevention and treatment of diarrheal diseases, respiratory diseases, limb and foot disease, and skin diseases in nursery pigs.

(7) Pay attention to grasping feed conversion and feeding techniques to prevent diarrheal diseases caused by feed changes.

(8) Breeders and technicians should observe the pig's dietary desire, urine, breathing and body temperature, exercise and rest, mental state, limb and hoof and skin changes, and whether the growth and development are good, and treat the pig disease in time.

Active Pharmaceutical Ingredient (API)

We are a manufacturer and supplier of raw materials, intermediates for pharmaceuticals, as well as Active Pharmaceutical Ingredient (API). Our focus is on providing customers with high quality, fair priced products, coupled with our broad range of technical know-hows on fundamentals, vast industrial experience on applications, professional expertise on health and safety, and efficient logistics on customer services. We have established good market for our intermediates in India, Korea and EU. Besides of their intermediates, we can also synthetize the API directly. We also have some API by fermentation, Polymyxin B Sulfate is one of them and we are developing more APIs as well.

Our production is based on GMP standard workshop, according to international Pharmacopoeia standard, making sure your experience with Sunshine Biotech is always enriching, satisfying and fulfilling.

Active Pharmaceutical Ingredient (API)

Active Pharmaceutical Ingredient,Polymyxin Sulfate,Ziprasidone Hcl,Polymyxin Sulphate

Nanjing Sunshine Biotech Co., Ltd , http://www.sunshine-bio.com